A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine
Abroad (travel likely)RecruitingPHASE3
Conditions
Pneumococcal Vaccines · Pneumococcal Infections
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Faculty of Medicine Udayana University, Denpasar, Bali, Indonesia
Contact: Study coordinator (Dr. dr. I Gusti Ayu Trisna Windiani, Sp.A(K), Doctor) · trisnawindianidr@yahoo.co.id · +62 813-3879-9222Universitas Padjadjaran Bandung, Bandung, Bandung, Indonesia
Contact: Study coordinator (Dr. Eddy Fadlyana, dr., Sp.A(K)., Mkes, Doctor) · edfadlyana@yahoo.com · +62 811-2320 - 259Faculty of Medicine, padjadjaran University, Bandung, Bandung, Indonesia
Contact: Study coordinator (Dr. Eddy Fadlyana, dr., Sp.A(K), M.Kes, Doctor) · edfadlyana@yahoo.com · +62 811-2320 - 259